Standard Life Aberdeen plc raised its stake in Perspecta Inc (NASDAQ:PRSP) by 8.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 63,795 shares of the company’s stock after purchasing an additional 5,213 shares during the period. Standard Life Aberdeen plc’s holdings in Perspecta were worth $1,032,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Martingale Asset Management L P increased its position in shares of Perspecta by 142.8% during the 4th quarter. Martingale Asset Management L P now owns 126,028 shares of the company’s stock worth $2,171,000 after purchasing an additional 74,125 shares in the last quarter. Royce & Associates LP increased its position in shares of Perspecta by 14.4% during the 4th quarter. Royce & Associates LP now owns 759,950 shares of the company’s stock worth $13,086,000 after purchasing an additional 95,500 shares in the last quarter. Eagle Asset Management Inc. increased its position in shares of Perspecta by 8.1% during the 4th quarter. Eagle Asset Management Inc. now owns 3,052,982 shares of the company’s stock worth $52,572,000 after purchasing an additional 228,661 shares in the last quarter. Texas Permanent School Fund increased its position in shares of Perspecta by 3.2% during the 4th quarter. Texas Permanent School Fund now owns 92,558 shares of the company’s stock worth $1,594,000 after purchasing an additional 2,878 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of Perspecta by 6.0% during the 4th quarter. Bank of New York Mellon Corp now owns 2,103,238 shares of the company’s stock worth $36,218,000 after purchasing an additional 119,356 shares in the last quarter.

PRSP opened at $20.50 on Friday. Perspecta Inc has a 1-year low of $15.74 and a 1-year high of $27.68.

Perspecta (NASDAQ:PRSP) last posted its quarterly earnings data on Wednesday, February 13th. The company reported $0.44 earnings per share for the quarter, meeting the consensus estimate of $0.44. The company had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.07 billion. The company’s revenue was up 48.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.42 EPS.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 16th. Shareholders of record on Wednesday, March 27th will be given a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend is Tuesday, March 26th.

Several research firms have weighed in on PRSP. Cowen restated a “buy” rating and issued a $28.00 price objective on shares of Perspecta in a research report on Wednesday, February 13th. Loop Capital set a $19.00 price objective on shares of Perspecta and gave the company a “hold prsp” rating in a research report on Monday, December 24th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Perspecta has an average rating of “Buy” and a consensus target price of $26.40.

ILLEGAL ACTIVITY NOTICE: This report was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://www.watchlistnews.com/standard-life-aberdeen-plc-raises-holdings-in-perspecta-inc-prsp/2897546.html.

Perspecta Profile

There is no company description available for Perspecta Inc

Recommended Story: Yield Curve

Want to see what other hedge funds are holding PRSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perspecta Inc (NASDAQ:PRSP).

Institutional Ownership by Quarter for Perspecta (NASDAQ:PRSP)

Receive News & Ratings for Perspecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perspecta and related companies with MarketBeat.com's FREE daily email newsletter.